GF
ETNB

Gabelli Funds’s 89bio ETNB Stock Holding History

Gabelli Funds’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-434,025
Closed -$6.38M – 1260
2025
Q3 		$6.38M Buy
+434,025
New +$4.42M 0.04% 432

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli Funds's ETNB Position: Q4 2025 in Review

Gabelli Funds sold out of 89bio (ETNB) in Q4 2025, closing a stake of 434,025 shares — an estimated $6.38M sold.

Gabelli Funds first reported a position in ETNB in Q3 2025 and held it in 1 quarter. The position peaked at $6.38M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Gabelli Funds reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Gabelli Funds sold 434,025 89bio shares in Q4 2025, an estimated $6.38M.
  • Gabelli Funds first reported a position in 89bio in Q3 2025 and held it in 1 quarter.
  • Gabelli Funds's 89bio position peaked at $6.38M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Gabelli Funds's 13F filing for Q4 2025, filed 5 Feb 2026.